» Articles » PMID: 20573992

Regulation of Circulating Progenitor Cells in Left Ventricular Dysfunction

Abstract

Background: Reductions in numbers of circulating progenitor cells (CD34+ cell subsets) have been demonstrated in patients at risk for, or in the presence of, cardiovascular disease. The mediators of these reductions remain undefined. To determine whether neurohumoral factors might regulate circulating CD34+ cell subsets in vivo, we studied complementary canine models of left ventricular (LV) dysfunction.

Methods And Results: A pacing model of severe LV dysfunction and a hypertensive renal wrap model in which dogs were randomized to receive deoxycorticosterone acetate (DOCA) were studied. Circulating CD34+ cell subsets including hematopoietic precursor cells (HPCs: CD34+/CD45(dim)/VEGFR2-) and endothelial progenitor cells (EPCs: CD34+/CD45-/VEGFR2+) were quantified. Additionally, the effect of mineralocorticoid excess on circulating progenitor cells in normal dogs was studied. The majority of circulating CD34+ cells expressed CD45dimly and did not express VEGFR2, consistent with an HPC phenotype. HPCs were decreased in response to pacing, and this decrease correlated with plasma aldosterone levels (Spearman rank correlation=-0.67, P=0.03). In the hypertensive renal wrap model, administration of DOCA resulted in decreased HPCs. No changes were seen in EPCs in either model. Normal dogs treated with DOCA exhibited a decrease in HPCs in peripheral blood but not bone marrow associated with decreased telomerase activity.

Conclusions: This is the first study to demonstrate that mineralocorticoid excess, either endogenous or exogenous, results in reduction in HPCs. These data suggest that mineralocorticoids may induce accelerated senescence of progenitor cells, leading to their reduced survival and decline in numbers.

Citing Articles

Feasibility of frailty screening among patients with advanced heart failure.

Lehto H, Jain N, Bernacki R, Landzberg M, Desai A, Orkaby A BMJ Open Qual. 2023; 12(4).

PMID: 37857523 PMC: 10603494. DOI: 10.1136/bmjoq-2023-002430.


Differential phenotype and behavior in culture of CD34 positive cells from peripheral blood and adipose tissue.

Froehlich H, Simari R, Boilson B Heliyon. 2021; 7(8):e07779.

PMID: 34458617 PMC: 8377488. DOI: 10.1016/j.heliyon.2021.e07779.


Isolation and Culture of Primary Endothelial Cells from Canine Arteries and Veins.

Oosterhoff L, Kruitwagen H, Spee B, van Steenbeek F J Vis Exp. 2016; (117).

PMID: 27911414 PMC: 5226248. DOI: 10.3791/54786.


Tachycardia pacing induces myocardial neovascularization and mobilizes circulating endothelial progenitor cells partly via SDF-1 pathway in canines.

Mai J, Wang F, Qiu Q, Tang B, Lin Y, Luo N Heart Vessels. 2014; 31(2):230-40.

PMID: 25491934 DOI: 10.1007/s00380-014-0613-5.

References
1.
Weber K . A neuroendocrine-immune interface. The immunostimulatory state of aldosteronism. Herz. 2003; 28(8):692-701. DOI: 10.1007/s00059-003-2511-y. View

2.
Pitt B, Zannad F, Remme W, Cody R, CASTAIGNE A, Perez A . The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med. 1999; 341(10):709-17. DOI: 10.1056/NEJM199909023411001. View

3.
Schmidt-Lucke C, Rossig L, Fichtlscherer S, Vasa M, Britten M, Kamper U . Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair. Circulation. 2005; 111(22):2981-7. DOI: 10.1161/CIRCULATIONAHA.104.504340. View

4.
Marumo T, Uchimura H, Hayashi M, Hishikawa K, Fujita T . Aldosterone impairs bone marrow-derived progenitor cell formation. Hypertension. 2006; 48(3):490-6. DOI: 10.1161/01.HYP.0000235681.25685.cf. View

5.
Shapiro B, Owan T, Mohammed S, Kruger M, Linke W, Burnett Jr J . Mineralocorticoid signaling in transition to heart failure with normal ejection fraction. Hypertension. 2007; 51(2):289-95. DOI: 10.1161/HYPERTENSIONAHA.107.099010. View